Non-Hodgkin's Lymphoma
Showing NaN - NaN of 20
Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)
Completed
- Non-Hodgkin's Lymphoma
- Plasma Cell Myeloma
- Hematopoietic Cell Transplantation
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022
Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)
Completed
- Non-Hodgkin's Lymphoma
- Bendamustine
- +6 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022
Non-Hodgkin's Lymphoma Trial in New York, Philadelphia, Houston (hA20-humanized anti-CD20 antibody)
Completed
- Non-Hodgkin's Lymphoma
- hA20-humanized anti-CD20 antibody
-
New York, New York
- +2 more
Aug 12, 2021
Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor
Recruiting
- Non-Hodgkin's Lymphoma
- +18 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Mar 11, 2021
Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated
Terminated
- Chronic Myelogenous Leukemia
- +7 more
- CD3/CD28 Activated T cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 12, 2020
Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)
Completed
- Non-Hodgkin's Lymphoma
-
Mobile, Alabama
- +120 more
Dec 20, 2019
Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)
Terminated
- Mantle Cell Lymphoma
- Non-Hodgkin's Lymphoma
- Lenalidomide
- Placebo
-
San Diego, California
- +91 more
Nov 6, 2019
Non-Hodgkin's Lymphoma Trial in Miami, Chicago, Philadelphia (Rituximab, bortezomib)
Completed
- Non-Hodgkin's Lymphoma
-
Miami, Florida
- +3 more
Aug 26, 2019
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
- bendamustine
- +5 more
-
Tucson, Arizona
- +127 more
Jan 8, 2018
Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)
Terminated
- Hematologic Malignancy
- +11 more
- Total Body Irradiation (TBI)
- +5 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Oct 19, 2016
Hematologic Malignancies, Acute Leukemia, MDS (MDS) Other Than RA or RARS Subtypes Trial in Philadelphia (drug, radiation,
Terminated
- Hematologic Malignancies
- +6 more
- Fludarabine
- +5 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Nov 28, 2016
B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Philadelphia (Bexxar)
Completed
- B-cell Lymphoma
- Non-Hodgkin's Lymphoma
-
Philadelphia, PennsylvaniaAbramson Cancer Center, University of Pennsylvania
Aug 15, 2016
Non-Hodgkin's Lymphoma Trial in United States (AME-133v (LY2469298))
Completed
- Non-Hodgkin's Lymphoma
- AME-133v (LY2469298)
-
Birmingham, Alabama
- +10 more
Jan 5, 2016
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Australia, Canada, United States (Bendamustine, Rituximab)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
-
Tucson, Arizona
- +42 more
Apr 7, 2014
Non-Hodgkin's Lymphoma Trial in United States (Iodine I 131 Tositumomab)
Completed
- Non-Hodgkin's Lymphoma
- Iodine I 131 Tositumomab
-
Bay Pines, Florida
- +5 more
Sep 13, 2007
Non-Hodgkin's Lymphoma Trial in United States (Zevalin (ibritumomab tiuxetan), Rituxan (rituximab))
Terminated
- Non-Hodgkin's Lymphoma
- Zevalin (ibritumomab tiuxetan)
- Rituxan (rituximab)
-
Huntsville, Alabama
- +66 more
Sep 8, 2006